Porter v. Tap Pharmaceutical, et al

Filing 593

Judge Richard G. Stearns: ORDER entered for issuance of cy pres payment to Dana Farber Cancer Institute in support of the Mazzone Awards Program. (Zierk, Marsha)

UNITED STATES DISTRICT COURT
DISTRICT OF MASSACHUSETTS
MDL NO. 1430
MASTER FILE NO. 01-CV-10861-RGS
IN RE: LUPRON® MARKETING AND
SALES PRACTICES LITIGATION
ORDER FOR ISSUANCE OF CY PRES
PAYMENT TO DANA FARBER CANCER INSTITUTE
IN SUPPORT OF THE MAZZONE AWARDS PROGRAM
May 3, 2018
STEARNS, D.J.
On May 1, 2018, the court granted Dana-Farber/Harvard Cancer
Center (DF/HCC) and the Prostate Cancer Foundation’s (PCF) request to
extend the end date of the Mazzone Program to September 30, 2019, and to
use unspent funding to support further research. The unspent funds held by
the court from the Lupron® Class Settlement Pool surplus is currently
$101,456.57. The court ORDERS the Court Registry Investment System to
issue a check in the amount of $50,728.29 to Dana Farber Cancer Institute
d/b/a Dana-Farber/Harvard Cancer Center to be deposited into a dedicated
account and used for the purposes set out in DF/HCC and PCF’s April 30,
2018 proposal. See Dkt #592 at 3-4. The court will disperse the balance of

the funds upon its approval of the final research progress and accounting
report (due September 30, 2019).
SO ORDERED.
/s/ Hon. Richard G. Stearns
UNITED STATES DISTRICT JUDGE

2